Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Lipitor, Apo-Atorvastatin, Atorsave F (Show all)
Generic Name: Atorvastatin
Atorvastatin is an antilipemic agent used for the treatment of lipid disorders, including hyperlipidemia or primary prevention of atherosclerotic cardiovascular disease.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| High Cholesterol | 257 | 49 |
|
|
|
|
|
| Other | 64 | 5 |
|
|
|
||
| Hypercholesterolemia | 59 | 7 |
|
|
|
||
| General health | 41 | 6 |
|
|
|
||
| Hyperlipidemia | 18 | 2 |
|
|
|||
| Increased lipids in blood (hyperlipidemia) | 15 | 4 |
|
|
|
See all 475 patients currently taking Atorvastatin
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Atorvastatin
| Joint tenderness | 6 | |
|---|---|---|
| Muscle aches | 6 | |
| Joints ache | 6 | |
| Muscle soreness | 6 | |
| Nausea | 2 | |
| Cramps in legs | 1 | |
| See all 30 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Atorvastatin. See all 18 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Doctor's advice | 39 | ||
| Side effects too severe | 33 | ||
| Other | 18 | ||
| Expense | 17 | ||
| Did not seem to work | 10 | ||
| Personal research | 10 | ||
| Change in health plan coverage | 9 | ||
| Course of treatment ended | 5 | ||
| Not indicated | 3 |
Adherence
Taking treatment as prescribed
Adherence of Atorvastatin
Always |
60 | 77% |
|
|---|---|---|---|
Usually |
10 | 13% |
|
Sometimes |
2 | 3% |
|
Never |
6 | 8% |
|
Burden
Difficulty being on treatment
Burden of Atorvastatin
Very |
2 | 3% |
|
|---|---|---|---|
Somewhat |
3 | 4% |
|
A little |
9 | 12% |
|
Not at all |
64 | 82% |
|
Cost
Paid out of pocket
Cost of Atorvastatin
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
3 | 5% |
|
$50-99 |
4 | 7% |
|
$25-49 |
13 | 23% |
|
< $25 |
35 | 63% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 25, 2012.